Diseases, Conditions, Syndromes

Researchers apply new immune technologies in search of mono vaccine

A research lab at the University of Kansas School of Engineering and School of Pharmacy is analyzing the genetics of human immune responses to develop the basis of an effective vaccine or drug therapy against Epstein-Barr ...

Diseases, Conditions, Syndromes

Untangling how Epstein-Barr virus infects cells

A team led by scientists at Northwestern Medicine has discovered a new epithelial receptor for Epstein-Barr virus, according to a study published recently in Nature Microbiology.

Oncology & Cancer

Cancer risk rises after childhood organ transplant: study

(HealthDay)—Children given an organ transplant have a substantially higher risk of developing cancer—in some cases up to 200 times higher—than the general population, a new study finds.

Oncology & Cancer

Armoring anti-cancer T cells against immunosuppressants

Duke-NUS Medical School researchers, together with collaborators in Singapore, have designed armored immune cells that can attack recurring cancer in liver transplant patients, while temporarily evading immunosuppressant ...

Diseases, Conditions, Syndromes

'Brain fog' can linger with long-haul COVID

As researchers work to learn more about COVID-19 and so-called long-haulers, a new study suggests "brain fog" can persist and even worsen for those who were infected months before.

page 9 from 15